Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | INMT | O95050 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TOP2A | P11388 | 1/20 | 0.30 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20469254 | 0.89 | CYP1A2 (0.34) | POLBINMTLMNATSHRCYP2D6 | |
| SCHEMBL18556746 | 0.88 | TOP2A (0.39) | CYP2D6TOP2ATOP2B | |
| SCHEMBL18993097 | 0.86 | CYP2D6 (0.36) | TSHRCYP3A4CYP2D6CYP2C19 | |
| SCHEMBL11686097 | 0.85 | ALDH1A1 (0.37) | INMTTSHRCYP2D6 | |
| SCHEMBL580377 | 0.83 | INMT (0.34) | POLBINMTLMNATSHRTOP2A | |
| SCHEMBL18827234 | 0.83 | CYP2D6 (0.39) | TSHRCYP3A4CYP2D6CYP2C19 | |
| SCHEMBL10955342 | 0.78 | CHRM2 (0.36) | POLBLMNATSHRCYP3A4CYP2D6 | |
| SCHEMBL22592262 | 0.76 | CYP2D6 (0.36) | TSHRCYP3A4CYP2D6CYP2C19 | |
| SCHEMBL8106145 | 0.73 | CYP1A2 (0.42) | LMNATSHRCYP2D6 | |
| SCHEMBL9164590 | 0.73 | TOP2A (0.35) | CYP2D6TOP2ATOP2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11225450-B2 | Processes for preparing calixarenes | SI GROUP, INC. (US) | 2022-01-18 | — | — | US | claimed |
| US-20210047253-A1 | PROCESSES FOR PREPARING CALIXARENES | SI GROUP, INC. | 2021-02-18 | — | — | US | claimed |
| US-10781154-B2 | Processes for preparing calixarenes | SI GROUP, INC. (US) | 2020-09-22 | — | — | US | claimed |
| US-10640641-B2 | Curable coating compositions of silane functional polymers | KING INDUSTRIES (US) | 2020-05-05 | — | — | US | claimed |
| US-20200062953-A1 | CURABLE COATING COMPOSITIONS OF SILANE FUNCTIONAL POLYMERS | KING INDUSTRIES | 2020-02-27 | — | — | US | claimed |
| US-20190248721-A1 | PROCESSES FOR PREPARING CALIXARENES | SI GROUP, INC. | 2019-08-15 | — | — | US | claimed |
| WO-2019157357-A1 | PROCESSES FOR PREPARING CALIXARENES | SI GROUP, INC. (US) | 2019-08-15 | — | — | WO | claimed |
| US-10336863-B2 | Curable composition having a special catalyst/softner system | HENKEL AG & CO. KGAA (DE) | 2019-07-02 | — | — | US | claimed |
| US-20180237635-A1 | CURABLE COATING COMPOSITIONS OF SILANE FUNCTIONAL POLYMERS | KING INDUSTRIES | 2018-08-23 | — | — | US | claimed |
| US-9976028-B2 | Curable coating compositions of silane functional polymers | KING INDUSTRIES (US) | 2018-05-22 | — | — | US | claimed |
| WO-2016137881-A1 | CURABLE COATING COMPOSITIONS OF SILANE FUNCTIONAL POLYMERS | KING INDUSTRIES (US) | 2016-09-01 | — | — | WO | claimed |
| US-20160244606-A1 | CURABLE COATING COMPOSITIONS OF SILANE FUNCTIONAL POLYMERS | KING INDUSTRIES | 2016-08-25 | — | — | US | claimed |
| US-8013080-B2 | Curable composition | KANEKA CORPORATION (JP) | 2011-09-06 | — | — | US | claimed |
| EP-4692247-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260022211-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2026-01-22 | — | — | US | disclosed |
| EP-4569023-A1 | COMBINATION OF CATALYTIC COMPONENTS | PolyU GmbH (DE) | 2025-06-18 | — | — | EP | disclosed |
| US-20090281236-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090171025-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| EP-1939256-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2008-07-02 | — | — | EP | disclosed |
| EP-1930376-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2008-06-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047253-A1 | PROCESSES FOR PREPARING CALIXARENES | CALU, CALD1, CALR | POLB 1641/4885INMT 3966/4885LMNA 2113/4885 |
| US-20190248721-A1 | PROCESSES FOR PREPARING CALIXARENES | CALU, CALD1, CALR | POLB 1641/4885INMT 3966/4885LMNA 2113/4885 |
| US-11225450-B2 | Processes for preparing calixarenes | CALU, CALD1, CALR | POLB 1641/4885INMT 3966/4885LMNA 2113/4885 |
| US-20260022211-A1 | CURABLE COMPOSITION | H1-4, H1-0, H1-2 | POLB 974/4885INMT 1112/4885LMNA 1462/4885 |
| US-10781154-B2 | Processes for preparing calixarenes | CALU, CALD1, CALR | POLB 1641/4885INMT 3966/4885LMNA 2113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.